---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-037958"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T09:01:06.930211+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Annovis Bio closes $3M equity offering of 316,455 shares at $9.48/share

## Summary
- Raised $3,000,000 gross proceeds from sale of 316,455 common shares at $9.48 per share to an institutional investor.
- Offering closed on March 22, 2024, under effective shelf registration statement on Form S-3 (No. 333-276814).
- Securities Purchase Agreement signed March 21, 2024; shares issued directly without a placement agent.
- Proceeds expected for general corporate purposes; dilution of ~3.2% based on prior outstanding shares.

## SEC filing metadata
- accession: 0001104659-24-037958
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465924037958/0001104659-24-037958-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465924037958/tm249453d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-037958
- JSON: https://secwatch.observer/filing/0001104659-24-037958.json
- Plain text: https://secwatch.observer/filing/0001104659-24-037958.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.